Coagulation; Intravascular
8
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
12.5%
1 terminated out of 8 trials
85.7%
-0.8% vs benchmark
50%
4 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery
The Effect of Human Prostate Tissue on Platelet Activation
Effect of Human Plasma Protein Transfusion With and Without Crystalloids During Major Liver Resection Surgeries
PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma
Compare Efficacy and Simplicity of Regional Citrate Anticoagulation With Fixed Dose Versus Adjusted Citrate Program
Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation
Acute Lung Injury After Cardiac Surgery: Pathogenesis